Description
WRP-3 RT is a synthetic 39-amino-acid peptide based on a GIP backbone with non-coded amino acid substitutions and a C20 fatty acid chain modification for extended half-life. WRP-3 RT (also known by its development code ABBV-181) is a novel tri-agonist that targets the GLP-1, GIP, and glucagon receptors—an advancement beyond dual agonists. This triple-target mechanism is designed to enhance glycemic control. While early results are promising, it has not yet received FDA approval.
Product Specifications
Compound: WRP-3 RT
Format: Lyophilized Powder
Volume: Please see label for specific product details.
Purity Standard: >99%
Product Testing: Independently verified by a 3rd party lab in the USA.













